Glenn A. Meyer
40Patents
12h-index
31Co-inventors
81Inventor score
Filing activity: Dec 31, 1991 → Jul 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5160742A | System for delivering an active substance for sustained release | Human Necessities | 84 | Expired |
| US6365180B1 | Oral liquid compositions | Human Necessities | 45 | Expired |
| US6287594A | Oral liquid compositions | Human Necessities | 44 | Expired |
| US8685451B2 | Triple combination release multi-layered tablet | Human Necessities | 34 | Active |
| US8574626B2 | Osmotic device containing amantadine and an osmotic salt | Human Necessities | 32 | Active |
| US8252331B2 | Osmotic device containing amantadine and an osmotic salt | Human Necessities | 29 | Active |
| US5294615A | Terazosin polymorph and pharmaceutical composition | Human Necessities | 26 | Expired |
| US6245352A | Pharmaceutical formulation | Human Necessities | 14 | Expired |
| US9585843B2 | Controlled release dosage form | Human Necessities | 13 | Active |
| US9801841B2 | Controlled release dosage form | Human Necessities | 13 | Active |
| US9579289B2 | Controlled release dosage form | Human Necessities | 13 | Active |
| US9655858B2 | Controlled release dosage form | Human Necessities | 13 | Active |
| US5599556A | Prolamine coatings for taste masking | Human Necessities | 9 | Expired |
| US5609909A | Prolamine coatings for taste masking | Human Necessities | 9 | Expired |
| US9833412B2 | Triple combination release multi-layered tablet | Human Necessities | 8 | Active |
| US8293799B2 | Osmotic device containing a venlafaxine salt and a salt having an ion in common | Human Necessities | 8 | Active |
| US6312723A | Pharmaceutical unit dosage form | Chemistry; Metallurgy | 7 | Expired |
| US10213393B1 | Composition and method for treating neurological disease | Human Necessities | 6 | Active |
| US10213394B1 | Composition and method for treating neurological disease | Human Necessities | 6 | Active |
| US6316020A | Pharmaceutical formulations | Chemistry; Metallurgy | 4 | Expired |
| US10500172B2 | Composition and method for treating neurological disease | Human Necessities | 2 | Active |
| US10512617B2 | Composition and method for treating neurological disease | Human Necessities | 2 | Active |
| US6312712A | Method of improving bioavailability | Chemistry; Metallurgy | 2 | Expired |
| US10500171B2 | Composition and method for treating neurological disease | Human Necessities | 2 | Active |
| US10500170B2 | Composition and method for treating neurological disease | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.